Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Valvular Heart Disease

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 172 articles:
HTML format



Single Articles


    May 2022

  1. Corrigendum to: The new European Society of Cardiology/European Association for Cardio-Thoracic Surgery recommendations for transcatheter aortic valve intervention are too restrictive.
    Eur Heart J. 2022 May 19. pii: 6588540. doi: 10.1093.
    PubMed    


  2. COLLET JP, Van Belle E, Thiele H, Berti S, et al
    Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial.
    Eur Heart J. 2022 May 18. pii: 6587401. doi: 10.1093.
    PubMed     Abstract available


  3. OECHSLIN L, Corti R, Biaggi P, Gaemperli O, et al
    Percutaneous closure of left ventricular pseudoaneurysm after direct surgical mitral valve implantation of balloon-expandable transcatheter prosthesis in severe mitral annular calcification.
    Eur Heart J. 2022;43:1884.
    PubMed    


  4. GALIUTO L, Massetti M
    To repair or not to repair: the dilemma of tricuspid regurgitation associated with left-sided valvular heart disease.
    Eur Heart J. 2022;43:1792-1793.
    PubMed    


  5. WILSON J, Muthumala A, Khanji MY
    Complete resolution of apical hypertrophy and fibrosis: the role of serial cardiovascular magnetic resonance tissue characterization to differentiate hypertrophic cardiomyopathy from myocarditis.
    Eur Heart J. 2022;43:1774.
    PubMed    


  6. TRIBOUILLOY C, Bohbot Y, Kubala M, Ruschitzka F, et al
    Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey.
    Eur Heart J. 2022 May 2. pii: 6576528. doi: 10.1093.
    PubMed     Abstract available


  7. CREA F
    Valvular heart disease: the quest for new pharmacological targets.
    Eur Heart J. 2022;43:1601-1604.
    PubMed    


  8. BEDEIR K, Robichaux RP, Gleason TG
    Surgical whole valve embolization 15 years after implantation.
    Eur Heart J. 2022;43:1685.
    PubMed    


  9. JANG SJ, Chen YH, Shen TC
    Pitfalls in recapture or repositioning of Evolut system using cusp overlap technique.
    Eur Heart J. 2022;43:1684.
    PubMed    


    April 2022
  10. WINDECKER S, Okuno T, Unbehaun A, Mack M, et al
    Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation?
    Eur Heart J. 2022 Apr 25. pii: 6572863. doi: 10.1093.
    PubMed     Abstract available


  11. DAYAN V, Gomes WJ
    The new ESC/EACTS recommendations for transcatheter aortic valve implantation go too far.
    Eur Heart J. 2022 Apr 25. pii: 6572861. doi: 10.1093.
    PubMed    


  12. THIELE H, Collet JP, Leon M, Mehran R, et al
    The new European Society of Cardiology/European Association for Cardio-Thoracic Surgery recommendations for transcatheter aortic valve intervention are too restrictive.
    Eur Heart J. 2022 Apr 25. pii: 6572862. doi: 10.1093.
    PubMed    


  13. CALCAGNO S, Di Pietro R, Biondi-Zoccai G, Versaci F, et al
    Cerebral protection device out of transcatheter heart procedures: a bridge to surgery.
    Eur Heart J. 2022;43:1598.
    PubMed    


    March 2022
  14. GALIUTO L, Massetti M
    To repair or not to repair: the dilemma of tricuspid regurgitation associated with left-sided valvular heart disease.
    Eur Heart J. 2022 Mar 10. pii: 6546148. doi: 10.1093.
    PubMed    


  15. TRENKWALDER T, Krane M
    Mitral valve prolapse: will genetics finally solve the puzzle?
    Eur Heart J. 2022 Mar 10. pii: 6546010. doi: 10.1093.
    PubMed    


  16. ROSELLI C, Yu M, Nauffal V, Georges A, et al
    Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse.
    Eur Heart J. 2022 Mar 4. pii: 6542554. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  17. KRALER S, Garg V, Akhmedov A
    Calcific aortic valve disease: novel insights into nitric oxide signalling.
    Eur Heart J. 2022 Feb 21. pii: 6533232. doi: 10.1093.
    PubMed    


  18. RUDOLPH V
    Heart and kidney: towards an integrated approach to secondary mitral regurgitation.
    Eur Heart J. 2022 Feb 18. pii: 6530471. doi: 10.1093.
    PubMed    



  19. Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thorac
    Eur Heart J. 2022 Feb 18. pii: 6533332. doi: 10.1093.
    PubMed    


  20. OECHSLIN L, Corti R, Biaggi P, Gaemperli O, et al
    Percutaneous closure of left ventricular pseudoaneurysm after direct surgical mitral valve implantation of balloon-expandable transcatheter prosthesis in severe mitral annular calcification.
    Eur Heart J. 2022 Feb 16. pii: 6531943. doi: 10.1093.
    PubMed    


  21. SCHMIADY MO, Carrel T, Sigler M, Eildermann K, et al
    Transcatheter mitral valve in ring implantation: a word of caution based on histopathological workup.
    Eur Heart J. 2022 Feb 15. pii: 6528555. doi: 10.1093.
    PubMed    


  22. CREA F
    A comprehensive update on valvular heart disease: from mechanisms to Guidelines.
    Eur Heart J. 2022;43:545-549.
    PubMed    


  23. COLOMBO A, Maisano F
    A new tool for the forgotten valve: a score to predict the risk of surgery.
    Eur Heart J. 2022;43:663-665.
    PubMed    


  24. PAUL JF, Lansac E, Chambon E, Neuvillers L, et al
    Aortic jet lesion: new insights with multimodal imaging.
    Eur Heart J. 2022;43:543.
    PubMed    


  25. LIU Z, Dong N, Hui H, Wang Y, et al
    Endothelial cell-derived tetrahydrobiopterin prevents aortic valve calcification.
    Eur Heart J. 2022 Feb 9. pii: 6525632. doi: 10.1093.
    PubMed     Abstract available


  26. IUNG B, Urena M
    New insights into transcatheter edge-to-edge repair: filling a gap for undertreatment of primary mitral regurgitation in the elderly?
    Eur Heart J. 2022;0.
    PubMed    


  27. BEOHAR N, Ailawadi G, Kotinkaduwa LN, Redfors B, et al
    Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial.
    Eur Heart J. 2022 Feb 3. pii: 6521532. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  28. BENFARI G, Sorajja P, Pedrazzini G, Taramasso M, et al
    Association of transcatheter edge-to-edge repair with improved survival in older patients with severe, symptomatic degenerative mitral regurgitation.
    Eur Heart J. 2022 Jan 28. pii: 6516827. doi: 10.1093.
    PubMed     Abstract available


  29. DREGOESC MI, Istrate M, Sandu I, Iancu AC, et al
    Massive biventricular thrombosis after transfemoral transcatheter aortic valve implantation.
    Eur Heart J. 2022 Jan 28. pii: 6516865. doi: 10.1093.
    PubMed    


  30. VOLPE M, Liuzzo G
    VANISHing the progression of cardiac abnormalities in hypertrophic cardiomyopathy with early use of valsartan?
    Eur Heart J. 2022;43:181-182.
    PubMed    


  31. BAUMGARTNER H, Iung B, Messika-Zeitoun D, Otto CM, et al
    The year in cardiovascular medicine 2021: valvular heart disease.
    Eur Heart J. 2022 Jan 3. pii: 6491394. doi: 10.1093.
    PubMed    


    December 2021
  32. WEERASEKARE JM, Geske JB
    'Heart within a heart': echocardiographic assessment of hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:4775.
    PubMed    


    November 2021
  33. BAUMGARTNER H
    Aortic stenosis management in 2021: better teaming up than fighting between specialties.
    Eur Heart J. 2021 Nov 28. pii: 6445126. doi: 10.1093.
    PubMed    


  34. NGUYEN V, Willner N, Eltchaninoff H, Burwash IG, et al
    Trends in aortic valve replacement for aortic stenosis: a French nationwide study.
    Eur Heart J. 2021 Nov 25. pii: 6439994. doi: 10.1093.
    PubMed     Abstract available


  35. KRALER S, Blaser MC, Aikawa E, Camici GG, et al
    Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy.
    Eur Heart J. 2021 Nov 25. pii: 6440005. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  36. DREYFUS J, Audureau E, Bohbot Y, Coisne A, et al
    TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery.
    Eur Heart J. 2021 Sep 29. pii: 6377884. doi: 10.1093.
    PubMed     Abstract available


  37. CHEN QQ, Ma G, Liu JF, Cai YY, et al
    Neuraminidase 1 is a driver of experimental cardiac hypertrophy.
    Eur Heart J. 2021;42:3770-3782.
    PubMed     Abstract available


  38. RAMAKUMAR V, Gupta A, Goswami KC, Jagia P, et al
    Mitral valvular nodules of acute rheumatic fever masquerading as intracardiac mass.
    Eur Heart J. 2021 Sep 16. pii: 6371300. doi: 10.1093.
    PubMed    


  39. VAHANIAN A, Praz F, Milojevic M, Beyersdorf F, et al
    The "ten commandments" for the 2021 ESC/EACTS Guidelines on valvular heart disease.
    Eur Heart J. 2021 Sep 16. pii: 6371303. doi: 10.1093.
    PubMed    


  40. NAUFFAL V, Marstrand P, Han L, Parikh VN, et al
    Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
    Eur Heart J. 2021 Sep 7. pii: 6365852. doi: 10.1093.
    PubMed     Abstract available


  41. MESSIKA-ZEITOUN D, Hibbert B, Chan V
    'Primary' percutaneous mitral valve repair in patients with acute myocardial infarction: is it ready for primetime?
    Eur Heart J. 2021 Sep 2. pii: 6362540. doi: 10.1093.
    PubMed    


    August 2021
  42. HABERMAN D, Estevez-Loureiro R, Benito-Gonzalez T, Denti P, et al
    Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction.
    Eur Heart J. 2021 Aug 31. pii: 6360026. doi: 10.1093.
    PubMed     Abstract available


  43. VAHANIAN A, Beyersdorf F, Praz F, Milojevic M, et al
    2021 ESC/EACTS Guidelines for the management of valvular heart disease.
    Eur Heart J. 2021 Aug 28. pii: 6358470. doi: 10.1093.
    PubMed    


  44. LOPES LR, Garcia-Hernandez S, Lorenzini M, Futema M, et al
    Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:3063-3073.
    PubMed     Abstract available


  45. WALSH R, Bezzina CR
    ALPK3: a full spectrum cardiomyopathy gene?
    Eur Heart J. 2021;42:3074-3077.
    PubMed    


  46. LAURI FM, Fernandez-Golfin C, Zamorano JL, Sanchez-Recalde A, et al
    Coronary compression caused by extrinsic adventitial damage: case of an early complication of trans-catheter tricuspid annuloplasty with cardioband device.
    Eur Heart J. 2021 Aug 18. pii: 6354189. doi: 10.1093.
    PubMed    


  47. BRAUNWALD E
    Reflections on Hypertrophic Cardiomyopathy.
    Eur Heart J. 2021;42:2969-2970.
    PubMed    


  48. TEN BERG J
    Antithrombotic therapy in patients undergoing trans catheter aortic valve implantation.
    Eur Heart J. 2021 Aug 9. pii: 6346754. doi: 10.1093.
    PubMed    


  49. DANGAS G, Nicolas J, Mehran R
    Single antiplatelet therapy after transcatheter aortic valve implantation: clarity on existing data.
    Eur Heart J. 2021 Aug 9. pii: 6346755. doi: 10.1093.
    PubMed    


  50. CREA F
    The new frontiers in valvular heart disease: from artificial intelligence to new pharmacological targets in aortic stenosis.
    Eur Heart J. 2021;42:2871-2875.
    PubMed    


  51. GHAREBAGHI N, Mehdizade H, Askari B, Mirza-Aghazadeh-Attari M, et al
    A bizarre foreign object in the heart: toothpick lodged in the tricuspid valve.
    Eur Heart J. 2021;42:2957.
    PubMed    


    July 2021
  52. TAMARGO J, Agewall S
    Fluoroquinolone use and valvular heart disease: is the jury still out?
    Eur Heart J. 2021 Jul 13. pii: 6319851. doi: 10.1093.
    PubMed    


  53. STRANGE JE, Holt A, Blanche P, Gislason G, et al
    Oral fluoroquinolones and risk of aortic or mitral regurgitation: a nationwide nested case-control study.
    Eur Heart J. 2021 Jul 10. pii: 6318706. doi: 10.1093.
    PubMed     Abstract available


  54. OYETUNJI SO, Otto CM
    Transcatheter aortic valve implantation or replacement? Valve durability in the context of patient life expectancy.
    Eur Heart J. 2021 Jul 1. pii: 6311995. doi: 10.1093.
    PubMed    


    June 2021
  55. ROGERS MA, Aikawa E
    Unbiased omics identifies mechanistic regulators of calcific aortic valve disease.
    Eur Heart J. 2021 Jun 28. pii: 6310290. doi: 10.1093.
    PubMed    


  56. JORGENSEN TH, Thyregod HGH, Ihlemann N, Nissen H, et al
    Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement.
    Eur Heart J. 2021 Jun 28. pii: 6310288. doi: 10.1093.
    PubMed     Abstract available


  57. WANG Y, Han D, Zhou T, Chen C, et al
    DUSP26 induces aortic valve calcification by antagonizing MDM2-mediated ubiquitination of DPP4 in human valvular interstitial cells.
    Eur Heart J. 2021 Jun 28. pii: 6310285. doi: 10.1093.
    PubMed     Abstract available


  58. XIE Y, Fang L, Li H, Xie M, et al
    Multimodality cardiac imaging for guidance of transapical transcatheter aortic valve implantation and mitral paravalvular leak closure.
    Eur Heart J. 2021 Jun 25. pii: 6309732. doi: 10.1093.
    PubMed    


  59. MALAGOLI A, Chiusolo S, Tondi S
    Isolated double-orifice mitral valve: an atypical morphology in adult patient.
    Eur Heart J. 2021 Jun 21. pii: 6307143. doi: 10.1093.
    PubMed    


  60. GOLIASCH G, Lang IM
    Impact of sex on the management and outcome of aortic stenosis patients: a female aortic valve stenosis paradox, and a call for personalized treatments?
    Eur Heart J. 2021 Jun 13. pii: 6297824. doi: 10.1093.
    PubMed    


  61. VINNAKOTA S, Jentzer JC, Luis SA
    Thrombolysis for COVID-19-associated bioprosthetic mitral valve thrombosis with shock.
    Eur Heart J. 2021 Jun 11. pii: 6296967. doi: 10.1093.
    PubMed    


  62. CREA F
    Dyslipidaemias in stroke, chronic kidney disease, and aortic stenosis: the new frontiers for cholesterol lowering.
    Eur Heart J. 2021;42:2137-2140.
    PubMed    


    May 2021
  63. BIENJONETTI-BOUDREAU D, Fleury MA, Voisine M, Paquin A, et al
    Impact of sex on the management and outcome of aortic stenosis patients.
    Eur Heart J. 2021 May 23. pii: 6282426. doi: 10.1093.
    PubMed     Abstract available


  64. KASKI JP
    Childhood-onset hypertrophic cardiomyopathy research coming of age.
    Eur Heart J. 2021;42:1997-1999.
    PubMed    


  65. MARSTON NA, Han L, Olivotto I, Day SM, et al
    Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:1988-1996.
    PubMed     Abstract available


  66. LANSKY AJ, Makkar R, Nazif T, Messe S, et al
    A randomized evaluation of the TriGuard HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial.
    Eur Heart J. 2021 May 17. pii: 6277114. doi: 10.1093.
    PubMed     Abstract available


  67. CALIGIURI G, Franck G
    Hitting the right channels to spread a 'no-restenosis' message to vascular wall cells.
    Eur Heart J. 2021;42:1786-1788.
    PubMed    


    April 2021
  68. GENEREUX P, Piazza N, Alu MC, Nazif T, et al
    Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research.
    Eur Heart J. 2021 Apr 19. pii: 6237954. doi: 10.1093.
    PubMed     Abstract available


  69. TEN BERG J, Sibbing D, Rocca B, Van Belle E, et al
    Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in coll
    Eur Heart J. 2021 Apr 5. pii: 6210683. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  70. CREA F
    Challenges in heart failure: quality of life, chronic kidney disease, and secondary mitral regurgitation.
    Eur Heart J. 2021;42:1185-1189.
    PubMed    


  71. COHEN-SHELLY M, Attia ZI, Friedman PA, Ito S, et al
    Electrocardiogram screening for aortic valve stenosis using artificial intelligence.
    Eur Heart J. 2021 Mar 22. pii: 6179522. doi: 10.1093.
    PubMed     Abstract available


  72. COATS AJS, Anker SD, Baumbach A, Alfieri O, et al
    The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and
    Eur Heart J. 2021 Mar 18. pii: 6174642. doi: 10.1093.
    PubMed     Abstract available


  73. DIBIE A, Landolff Q, Veugeois A, Amabile N, et al
    Chimney technique in a TAVR-in-TAVR procedure with high risk of left main artery ostium occlusion.
    Eur Heart J. 2021;42:1051.
    PubMed    


    February 2021
  74. CASE BC, Ben-Dor I, Satler LF, Waksman R, et al
    Rescue alcohol septal ablation for dynamic left ventricular outflow tract obstruction and haemodynamic collapse after transcatheter aortic valve implantation.
    Eur Heart J. 2021 Feb 21. pii: 6145857. doi: 10.1093.
    PubMed    


  75. CREA F
    New guidelines on adult congenital heart disease, the fantastic four in the treatment of heart failure, and also what happened in the last year in heart failure and valvular heart disease.
    Eur Heart J. 2021;42:551-554.
    PubMed    


  76. WOLDENDORP K, Indja B, Bannon PG, Fanning JP, et al
    Silent brain infarcts and early cognitive outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis.
    Eur Heart J. 2021 Feb 1. pii: 6124789. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  77. KRONENBERG F
    Aortic valve stenosis: the long and winding road.
    Eur Heart J. 2021 Jan 31. pii: 6124840. doi: 10.1093/eurheartj/ehaa1069.
    PubMed    


  78. QUERCIOLI A, Capettini AC, Gherli R, Secco GG, et al
    Three-dimensional echo guidance of percutaneous mitral paravalvular leak closure.
    Eur Heart J. 2021;42:359.
    PubMed    


  79. GOPALAMURUGAN AB, Anantharaman R, Abubacker M, Varshaa GM, et al
    First-in-man proof of feasibility: PCI, TAVR, and TEVAR of aortic arch with a hybrid approach through a trans-caval (cavo-aortic) access in the same procedure.
    Eur Heart J. 2021;42:357.
    PubMed    


  80. PEREZ DE ISLA L, Watts GF, Alonso R, Diaz-Diaz JL, et al
    Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia.
    Eur Heart J. 2021 Jan 12. pii: 6091158. doi: 10.1093/eurheartj/ehaa1066.
    PubMed     Abstract available


  81. GALIUTO L, Patrono C
    Rivaroxaban, a novel option for patients with atrial fibrillation and a bioprosthetic mitral valve.
    Eur Heart J. 2021 Jan 4. pii: 6062729. doi: 10.1093/eurheartj/ehaa1075.
    PubMed    


  82. BERMEJO J, Postigo A, Baumgartner H
    The year in cardiovascular medicine 2020: valvular heart disease.
    Eur Heart J. 2021 Jan 3. pii: 6060050. doi: 10.1093/eurheartj/ehaa1060.
    PubMed    


  83. NICHOLLS M
    The Year in Cardiovascular Medicine 2020: Valvular Heart Disease.
    Eur Heart J. 2021 Jan 3. pii: 6060073. doi: 10.1093/eurheartj/ehaa1024.
    PubMed    


    December 2020
  84. QIAN H, Li Y, Qin Y, Huang H, et al
    An unusual left ventricle pseudo-aneurysm with progressive mitral regurgitation.
    Eur Heart J. 2020 Dec 31. pii: 6056658. doi: 10.1093/eurheartj/ehaa1076.
    PubMed    


  85. CHEN J, Wei L, Wang C
    The impact of minimally invasive technique on the outcomes of isolated tricuspid valve surgery.
    Eur Heart J. 2020 Dec 12. pii: 6031686. doi: 10.1093.
    PubMed    


  86. VERMEERSCH G, Prihadi E, De Keulenaer G, Vermeersch P, et al
    Giant native aortic valve thrombus under non-vitamin K antagonist oral anticoagulant: first manifestation of antiphospholipid syndrome.
    Eur Heart J. 2020 Dec 11. pii: 6030876. doi: 10.1093.
    PubMed    


  87. AKAZAWA Y, Higaki T, Moritani T, Yamaguchi O, et al
    Acute mitral valve occlusion caused by atrial septal defect occluder.
    Eur Heart J. 2020 Dec 11. pii: 6031437. doi: 10.1093.
    PubMed    


  88. CREA F
    Challenges in risk stratification of symptomatic and asymptomatic valvular heart disease: lessons from large observational studies.
    Eur Heart J. 2020;41:4289-4292.
    PubMed    


  89. TOTH E, Dancy L, Amin-Youssef G, Papachristidis A, et al
    Collateral implications of the COVID-19 pandemic: belated presentation of infective endocarditis in a young patient.
    Eur Heart J. 2020;41:4365.
    PubMed    


    November 2020
  90. HAHN RT
    Degenerative mitral stenosis: interpreting the meaning of mean gradient.
    Eur Heart J. 2020 Nov 30. pii: 6010480. doi: 10.1093.
    PubMed    


  91. BERTRAND PB, Churchill TW, Yucel E, Namasivayam M, et al
    Prognostic importance of the transmitral pressure gradient in mitral annular calcification with associated mitral valve dysfunction.
    Eur Heart J. 2020 Nov 22. pii: 5998318. doi: 10.1093.
    PubMed     Abstract available


  92. SONG L, Jin J, Ma X, Xu M, et al
    Aortic dissection and rupture in a 3-year-old boy with bicuspid aortic valve.
    Eur Heart J. 2020 Nov 17. pii: 5986680. doi: 10.1093.
    PubMed    


  93. REID A, Blanke P, Bax JJ, Leipsic J, et al
    Multimodality imaging in valvular heart disease: how to use state-of-the-art technology in daily practice.
    Eur Heart J. 2020 Nov 13. pii: 5981494. doi: 10.1093.
    PubMed     Abstract available


  94. WATANABE M, Miyachi H, Uchiyama S, Shimizu W, et al
    Thickening of the sinus of Valsalva wall and aortic valve leaflet in a case of Takayasu's arteritis.
    Eur Heart J. 2020 Nov 12. pii: 5979511. doi: 10.1093.
    PubMed    


  95. ALIZADEHASL A, Salehi P, Roudbari S, Peighambari MM, et al
    Infectious endocarditis of the prosthetic mitral valve after COVID-19 infection.
    Eur Heart J. 2020 Nov 7. pii: 5960182. doi: 10.1093.
    PubMed    


  96. GALIUTO L, Patrono C
    New hope for targeted treatment of obstructive hypertrophic cardiomyopathy: comment on the EXPLORER-HCM trial.
    Eur Heart J. 2020;41:4089-4090.
    PubMed    


  97. SHARMA A, Bertog S, Mbai M
    Transcatheter aortic valve lithotripsy in severely calcified bicuspid aortic stenosis prior to transcatheter aortic valve implantation.
    Eur Heart J. 2020 Nov 6. pii: 5959818. doi: 10.1093.
    PubMed    


    October 2020
  98. IDRIS A, Smith Ii RL, Ryan WH, Wang Z, et al
    Primary malignant fibrous histiocytoma of the mitral valve as a rare incidental finding.
    Eur Heart J. 2020 Oct 17. pii: 5927542. doi: 10.1093.
    PubMed    


  99. SWEDA R, Berger D, Heverhagen JT, Hunziker L, et al
    Pulmonary haemorrhage on veno-arterial ECMO: consequences of missed aortic valve regurgitation.
    Eur Heart J. 2020 Oct 14. pii: 5922864. doi: 10.1093.
    PubMed    


    September 2020
  100. DELGADO V, Ajmone Marsan N, Bax JJ
    The difficult decision of when and in whom to perform isolated tricuspid valve surgery.
    Eur Heart J. 2020 Sep 27. pii: 5912178. doi: 10.1093.
    PubMed    


  101. VALLABHAJOSYULA S, Said SM, Kitzmann AS, Michelena HI, et al
    Accelerated extensive mitral valve calcification in a young end-stage kidney disease patient.
    Eur Heart J. 2020 Sep 27. pii: 5912177. doi: 10.1093.
    PubMed    


  102. GARBI M, Lancellotti P
    Heart Valve Specialist Core Syllabus of the ESC Council on Valvular Heart Disease.
    Eur Heart J. 2020 Sep 25. pii: 5911420. doi: 10.1093.
    PubMed    


  103. DREYFUS J, Flagiello M, Bazire B, Eggenspieler F, et al
    Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes.
    Eur Heart J. 2020 Sep 25. pii: 5911419. doi: 10.1093.
    PubMed     Abstract available


  104. BAUMGARTNER H
    The new European Heart Journal Valvular Heart Disease Team.
    Eur Heart J. 2020 Sep 15. pii: 5906089. doi: 10.1093.
    PubMed    


  105. BAUMGARTNER H, Iung B, Otto CM
    Timing of intervention in asymptomatic patients with valvular heart disease.
    Eur Heart J. 2020 Sep 9. pii: 5903163. doi: 10.1093.
    PubMed     Abstract available


  106. NG ACT, Holmes DR, Mack MJ, Delgado V, et al
    Leaflet immobility and thrombosis in transcatheter aortic valve replacement.
    Eur Heart J. 2020;41:3184-3197.
    PubMed     Abstract available


    August 2020
  107. TARANTINI G, Cardaioli F, Pavei A, Fabris T, et al
    Unfolding of unexpected and extreme transcatheter aortic valve distortion.
    Eur Heart J. 2020 Aug 18. pii: 5893662. doi: 10.1093.
    PubMed    


  108. FERLINI M, Mauri S
    Variable rate of stroke after transcatheter aortic valve replacement with self-expandable valves: more doubts than certainties.
    Eur Heart J. 2020 Aug 18. pii: 5893661. doi: 10.1093.
    PubMed    


  109. THIELE H, Abdel-Wahab M, Desch S
    Stroke rates after transcatheter aortic valve replacement: does valve choice play a role?
    Eur Heart J. 2020 Aug 18. pii: 5893660. doi: 10.1093.
    PubMed    


  110. MARONA M, Celinska-Spodar M, Spiewak M, Konopka A, et al
    Stress-induced cardiac arrest with mitral annulus disjunction in a physician amid the COVID-19 pandemic fight.
    Eur Heart J. 2020;41:2921.
    PubMed    


  111. MOHTY D, Pibarot P, Damy T
    Aortic stenosis and amyloid heart disease: 'the 2A dangerous liaisons'.
    Eur Heart J. 2020;41:2815.
    PubMed    


  112. MATSUSHITA K, Hess S, Ohlmann P, Morel O, et al
    Accordion phenomenon in the descending aorta during transcatheter aortic valve replacement followed by mesenteric ischaemia.
    Eur Heart J. 2020;41:2819.
    PubMed    


  113. LUSCHER TF
    Frontiers in valvular heart disease: outcomes of novel percutaneous procedures.
    Eur Heart J. 2020;41:2717-2720.
    PubMed    


    July 2020
  114. BEIRAS-FERNANDEZ A, Ruf TF, Obadia JI, Munzel T, et al
    Neochord anterior leaflet treatment to facilitate transcatheter mitral valve replacement with 3D real-time echocardiography.
    Eur Heart J. 2020 Jul 29. pii: 5877565. doi: 10.1093.
    PubMed    


  115. KALRA DK, Arora A, Kavinsky C
    A gigantic right atrium due to tricuspid valve dysfunction.
    Eur Heart J. 2020 Jul 29. pii: 5877567. doi: 10.1093.
    PubMed    


  116. HIRJI S, Zogg CK, Kaneko T
    The utility of the nationwide readmissions database in understanding contemporary transcatheter aortic valve replacement outcomes.
    Eur Heart J. 2020 Jul 17. pii: 5873282. doi: 10.1093.
    PubMed    


  117. NAZIR S, Ahuja KR, Alamir MA
    Is the national readmission database the right database to identify valve-in-valve transcatheter aortic valve replacement patients?
    Eur Heart J. 2020 Jul 17. pii: 5873284. doi: 10.1093.
    PubMed    


  118. FALK RH, Dorbala S
    Transthyretin cardiac amyloidosis in patients with severe aortic stenosis.
    Eur Heart J. 2020 Jul 8. pii: 5868579. doi: 10.1093.
    PubMed    


  119. NAZARZADEH M, Rahimi K
    Mendelian randomization of plasma lipids and aortic valve stenosis: the importance of outlier variants and population stratification.
    Eur Heart J. 2020 Jul 6. pii: 5867643. doi: 10.1093.
    PubMed    


    June 2020
  120. ROMMEL KP, Lurz P
    Transcatheter tricuspid valve repair and pulmonary hypertension: navigating through troubled waters.
    Eur Heart J. 2020 Jun 30. pii: 5865477. doi: 10.1093.
    PubMed    


  121. JIANG Q, Chen M
    Assessing causality in associations of lipid levels with aortic valve stenosis.
    Eur Heart J. 2020 Jun 30. pii: 5865472. doi: 10.1093.
    PubMed    


  122. D'ALTO M, Naeije R
    Transcatheter tricuspid valve repair in patients with pulmonary hypertension.
    Eur Heart J. 2020 Jun 30. pii: 5865473. doi: 10.1093.
    PubMed    


  123. BLEIZIFFER S, Simonato M, Webb JG, Rodes-Cabau J, et al
    Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves.
    Eur Heart J. 2020 Jun 27. pii: 5863929. doi: 10.1093.
    PubMed     Abstract available


  124. VARGA A, Hegele RA
    Triglyceride-rich particles: new actors in valvular aortic stenosis.
    Eur Heart J. 2020;41:2300-2303.
    PubMed    


  125. IUNG B, Wendler O
    Valve-in-valve vs. repeat surgical aortic valve replacement: a new match but the game is not over!
    Eur Heart J. 2020 Jun 12. pii: 5856871. doi: 10.1093.
    PubMed    


  126. VARELA-CANCELO A, Salgado-Fernandez J, Calvino-Santos R, Bouzas-Zubeldia B, et al
    Successful transfemoral management of transcatheter aortic valve embolization into left ventricle.
    Eur Heart J. 2020 Jun 4. pii: 5851539. doi: 10.1093.
    PubMed    


    May 2020
  127. HIRJI SA, Percy ED, Zogg CK, Malarczyk A, et al
    Comparison of in-hospital outcomes and readmissions for valve-in-valve transcatheter aortic valve replacement vs. reoperative surgical aortic valve replacement: a contemporary assessment of real-world outcomes.
    Eur Heart J. 2020 May 23. pii: 5841644. doi: 10.1093.
    PubMed     Abstract available


  128. LUSCHER TF
    From TAVI to tricuspid cliping: fine-tuning the management of valvular heart disease.
    Eur Heart J. 2020;41:1863-1866.
    PubMed    


  129. NAZARZADEH M, Rahimi K
    Limitations of subgroup analysis of underpowered clinical trials for making causal inference about treatment effects.
    Eur Heart J. 2020;41:1942.
    PubMed    


  130. NICKENIG G, Vogelhuber J
    The tricuspid tragedy: from Cinderella to celebrity.
    Eur Heart J. 2020;41:1930-1931.
    PubMed    


  131. WEBB J, Wood D, Sathananthan J, Landes U, et al
    Balloon-expandable or self-expandable transcatheter heart valves. Which are best?
    Eur Heart J. 2020;41:1900-1902.
    PubMed    


  132. GREVE AM
    High low-density lipoprotein levels and high risk of aortic stenosis.
    Eur Heart J. 2020 May 7. pii: 5831945. doi: 10.1093.
    PubMed    


    April 2020
  133. NIENABER CA, Yuan X
    Lipid levels linked to symptomatic aortic valve stenosis: evidence from Mendelian randomization?
    Eur Heart J. 2020 Apr 29. pii: 5827054. doi: 10.1093.
    PubMed    


  134. FERNANDEZ GASSO L, Jimenez Lopez-Guarch C, Garcia Robles JA, Solis J, et al
    Double-orifice mitral valve associated with multivalvular involvement: a new entity?
    Eur Heart J. 2020 Apr 26. pii: 5825474. doi: 10.1093.
    PubMed    


  135. COLOMBIER S, Alexe R, Tapponnier M, Delay D, et al
    45 years of prosthetic mitro-aortic valve technology in a single heart.
    Eur Heart J. 2020 Apr 26. pii: 5825472. doi: 10.1093.
    PubMed    


  136. CHEN Y, Waksman R, Satler L, Barnett C, et al
    Percutaneous transcatheter release of stuck mechanical mitral valve leaflet.
    Eur Heart J. 2020 Apr 20. pii: 5822833. doi: 10.1093.
    PubMed    


  137. ESSAYAGH B, Antoine C, Benfari G, Maalouf J, et al
    Functional tricuspid regurgitation of degenerative mitral valve disease: a crucial determinant of survival.
    Eur Heart J. 2020 Apr 16. pii: 5821042. doi: 10.1093.
    PubMed     Abstract available


  138. LI Y, Ji P, Qian H, Rao L, et al
    A rare anomaly: truncus arteriosus or pulmonary atresia.
    Eur Heart J. 2020 Apr 15. pii: 5820563. doi: 10.1093.
    PubMed    


  139. NIETO-ROCA L, Tomas-Mallebrera M, Aldamiz-Echevarria Del Castillo G
    "King size" asymptomatic aortic aneurysm after bicuspid aortic valve surgery.
    Eur Heart J. 2020 Apr 14. pii: 5819671. doi: 10.1093.
    PubMed    


  140. MURAKAMI T, Ohno Y, Nakazawa G, Ikari Y, et al
    Transjugular intracardiac echocardiography-guided transcatheter aortic valve implantation.
    Eur Heart J. 2020 Apr 14. pii: 5819673. doi: 10.1093.
    PubMed    


  141. KALTOFT M, Langsted A, Nordestgaard BG
    Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study.
    Eur Heart J. 2020 Apr 8. pii: 5817922. doi: 10.1093.
    PubMed     Abstract available


  142. SCULLY PR, Patel KP, Treibel TA, Thornton GD, et al
    Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation.
    Eur Heart J. 2020 Apr 8. pii: 5817909. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  143. KONG WKF, Bax JJ, Delgado V
    Left ventricular myocardial fibrosis: a marker of bad prognosis in symptomatic severe aortic stenosis.
    Eur Heart J. 2020 Mar 24. pii: 5811373. doi: 10.1093.
    PubMed    


  144. LURZ P, Orban M, Besler C, Braun D, et al
    Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair.
    Eur Heart J. 2020 Mar 16. pii: 5807655. doi: 10.1093.
    PubMed     Abstract available


  145. HAHN RT
    Finding concordance in discord: the value of discordant invasive and echocardiographic pulmonary artery pressure measurements with severe tricuspid regurgitation.
    Eur Heart J. 2020 Mar 16. pii: 5807654. doi: 10.1093.
    PubMed    


  146. ALVAREZ-COVARRUBIAS HA, Xhepa E, Michel JM, Kasel AM, et al
    1000 mm2 plus aortic annulus: successful treatment of a giant bicuspid aortic valve with a Sapien 3 transcatheter heart valve.
    Eur Heart J. 2020 Mar 10. pii: 5802606. doi: 10.1093.
    PubMed    


  147. SCHMIADY MO, Taramasso M, Maisano F, Sigler M, et al
    Mitral valve surgery after MitraClip(R) implantation: what histopathology can tell us?
    Eur Heart J. 2020 Mar 6. pii: 5788531. doi: 10.1093.
    PubMed    


  148. PARR CJ, Kass M, Yamashita MH, Jassal DS, et al
    Thrombosis of a mechanical mitral valve: a sticky situation.
    Eur Heart J. 2020 Mar 4. pii: 5780423. doi: 10.1093.
    PubMed    


    February 2020
  149. JERING KS, Pfeffer MA
    From practice changing to hypothesis generating: a virtuous cycle.
    Eur Heart J. 2020;41:955-957.
    PubMed    


  150. LUSCHER TF
    Valvular heart disease: improved procedural success and prediction of outcomes.
    Eur Heart J. 2020;41:899-902.
    PubMed    


  151. KHOR L, Simmons LA, Von Bardeleben RS, Ng MK, et al
    Transcatheter edge-to-edge repair for tricuspid regurgitation in Barlow-type tricuspid valve prolapse.
    Eur Heart J. 2020 Feb 20. pii: 5741384. doi: 10.1093.
    PubMed    


  152. NAZARZADEH M, Pinho-Gomes AC, Bidel Z, Dehghan A, et al
    Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study.
    Eur Heart J. 2020 Feb 20. pii: 5740546. doi: 10.1093.
    PubMed     Abstract available


  153. THIELE H, Kurz T, Feistritzer HJ, Stachel G, et al
    Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial.
    Eur Heart J. 2020 Feb 12. pii: 5734668. doi: 10.1093.
    PubMed     Abstract available


  154. PULS M, Beuthner BE, Topci R, Vogelgesang A, et al
    Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis.
    Eur Heart J. 2020 Feb 12. pii: 5734676. doi: 10.1093.
    PubMed     Abstract available


  155. HAMM CW, Beyersdorf F
    GARY-The Largest Registry of Aortic Stenosis Treatment Worldwide.
    Eur Heart J. 2020;41:733-735.
    PubMed    


    January 2020
  156. AUFFRET V, Puri R, Leurent G, Le Breton H, et al
    Conduction disturbances following trancatheter aortic valve implantation: increasing the 'pace' towards prospective evidence.
    Eur Heart J. 2020 Jan 20. pii: 5710689. doi: 10.1093.
    PubMed    


  157. SONDERGAARD L
    Durability of transcatheter bioprosthetic aortic valves.
    Eur Heart J. 2020 Jan 6. pii: 5697053. doi: 10.1093.
    PubMed    


  158. RUBATTU S, Volpe M
    BNP level and post-transcatheter aortic valve replacement outcome: an intriguing J-shaped relationship.
    Eur Heart J. 2020 Jan 6. pii: 5697062. doi: 10.1093.
    PubMed    


  159. TESTA L, Latib A, Brambilla N, De Marco F, et al
    Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis.
    Eur Heart J. 2020 Jan 6. pii: 5697056. doi: 10.1093.
    PubMed     Abstract available


  160. BINDER RK, Dweck M, Prendergast B
    The year in cardiology: valvular heart disease.
    Eur Heart J. 2020 Jan 6. pii: 5694320. doi: 10.1093.
    PubMed    


  161. FAROUX L, Chen S, Muntane-Carol G, Regueiro A, et al
    Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis.
    Eur Heart J. 2020 Jan 3. pii: 5695667. doi: 10.1093.
    PubMed     Abstract available


    December 2019
  162. CHEN S, Redfors B, O'Neill BP, Clavel MA, et al
    Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry.
    Eur Heart J. 2019 Dec 28. pii: 5688929. doi: 10.1093.
    PubMed     Abstract available


  163. SIA CH, Gochuico CFS, Ong CC, Teo LL, et al
    A man with end-stage renal failure and uncontrolled hyperparathyroidism with repeat transcatheter aortic valve replacement in a surgical bioprosthetic aortic valve while avoiding patient-prosthesis mismatch.
    Eur Heart J. 2019 Dec 22. pii: 5684840. doi: 10.1093.
    PubMed    


  164. YERASI C, O'Donoghue S, Satler LF, Waksman R, et al
    Apple Watch detecting high-grade block after transcatheter aortic valve implantation.
    Eur Heart J. 2019 Dec 3. pii: 5651110. doi: 10.1093.
    PubMed    


    November 2019
  165. EBERHARD M, Hermann M, Stahli BE, Manka R, et al
    Amphetamine-induced coronary artery dissection and massive aortic valve thrombus.
    Eur Heart J. 2019 Nov 25. pii: 5640488. doi: 10.1093.
    PubMed    


  166. CHEN S, Redfors B, Nazif T, Kirtane A, et al
    Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries.
    Eur Heart J. 2019 Nov 11. pii: 5621355. doi: 10.1093.
    PubMed     Abstract available


  167. RUMPF PM, Michel JM, Xhepa E, Kasel AM, et al
    Paravalvular leakage due to ring dehiscence after mitral valve-in-ring therapy: mechanisms and percutaneous treatment.
    Eur Heart J. 2019 Nov 5. pii: 5613227. doi: 10.1093.
    PubMed    


    October 2019
  168. LIN AE, Libby P, Ebert BL
    A new opening on aortic stenosis: predicting prognosis with clonal haematopoiesis.
    Eur Heart J. 2019 Oct 21. pii: 5601845. doi: 10.1093.
    PubMed    


  169. MONTEAGUDO RUIZ JM, Zamorano Gomez JL
    Endocarditis after transcatheter aortic valve implantation: a new fiend we hardly know.
    Eur Heart J. 2019 Oct 7. pii: 5583201. doi: 10.1093.
    PubMed    


    September 2019
  170. ABDEL-WAHAB M, Kitamura M, Holzhey D, Thiele H, et al
    Transcatheter aortic valve implantation with a new generation mechanically expanding valve in a patient with a protruding coronary stent into the sinus of Valsalva: the 'reversed-chimney' technique.
    Eur Heart J. 2019 Sep 24. pii: 5573049. doi: 10.1093.
    PubMed    


    December 2018
  171. OBOKATA M, Reddy YNV, Melenovsky V, Pislaru S, et al
    Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction.
    Eur Heart J. 2018 Dec 12. pii: 5240922. doi: 10.1093.
    PubMed     Abstract available


    December 2017
  172. GALIE N, Manes A, Dardi F, Palazzini M, et al
    Aiming at the appropriate target for the treatment of pulmonary hypertension due to left heart disease.
    Eur Heart J. 2017 Dec 27. pii: 4780182. doi: 10.1093.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: